PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s share price rose 4.2% during mid-day trading on Tuesday . The company traded as high as $1.75 and last traded at $1.75. Approximately 10,000 shares changed hands during mid-day trading, an increase of 50% from the average daily volume of 6,652 shares. The stock had previously closed at $1.68.
PureTech Health Stock Up 4.2%
The stock’s 50 day moving average price is $1.64 and its 200-day moving average price is $1.77.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Manufacturing Stocks Investing
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
